Myriad Genetics MYGN Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's operating lease liabilities?
- Myriad Genetics (MYGN) reported operating lease liabilities of $84.1M in Q1 2026.
- How has Myriad Genetics's operating lease liabilities changed year-over-year?
- Myriad Genetics's operating lease liabilities decreased by 3.8% year-over-year, from $87.4M to $84.1M.
- What is the long-term trend for Myriad Genetics's operating lease liabilities?
- Over 5 years (2020 to 2025), Myriad Genetics's operating lease liabilities has grown at a 10.4% compound annual growth rate (CAGR), from $50.6M to $83M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.